These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35392357)

  • 21. Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.
    Resalat N; Hilts W; Youssef JE; Tyler N; Castle JR; Jacobs PG
    J Diabetes Sci Technol; 2019 Nov; 13(6):1044-1053. PubMed ID: 31595784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
    Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.
    Toffanin C; Visentin R; Messori M; Palma FD; Magni L; Cobelli C
    IEEE Trans Biomed Eng; 2018 Mar; 65(3):479-488. PubMed ID: 28092515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
    Song L; Liu C; Yang W; Zhang J; Kong X; Zhang B; Chen X; Wang N; Shen D; Li Z; Jin X; Shuai Y; Wang Y
    Comput Methods Programs Biomed; 2020 Jul; 191():105416. PubMed ID: 32146213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems.
    Chakrabarty A; Zavitsanou S; Doyle FJ; Dassau E
    IEEE Trans Biomed Eng; 2018 Mar; 65(3):575-586. PubMed ID: 28541890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
    Buckingham BA; Christiansen MP; Forlenza GP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Sep; 20(9):585-595. PubMed ID: 30070928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
    Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
    J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
    Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal Glucose Control in Type 1 Diabetes Using Deep Reinforcement Learning: An In Silico Validation.
    Zhu T; Li K; Herrero P; Georgiou P
    IEEE J Biomed Health Inform; 2021 Apr; 25(4):1223-1232. PubMed ID: 32755873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal Insulin Delivery: Evidence of a Physiological Route for Artificial Pancreas From Compartmental Modeling.
    Lo Presti J; Galderisi A; Doyle FJ; Zisser HC; Dassau E; Renard E; Toffanin C; Cobelli C
    J Diabetes Sci Technol; 2023 May; 17(3):751-756. PubMed ID: 35144503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
    Pinsker JE; Lee JB; Dassau E; Seborg DE; Bradley PK; Gondhalekar R; Bevier WC; Huyett L; Zisser HC; Doyle FJ
    Diabetes Care; 2016 Jul; 39(7):1135-42. PubMed ID: 27289127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First use of model predictive control in outpatient wearable artificial pancreas.
    Del Favero S; Bruttomesso D; Di Palma F; Lanzola G; Visentin R; Filippi A; Scotton R; Toffanin C; Messori M; Scarpellini S; Keith-Hynes P; Kovatchev BP; Devries JH; Renard E; Magni L; Avogaro A; Cobelli C;
    Diabetes Care; 2014; 37(5):1212-5. PubMed ID: 24757228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 35. In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems.
    Toffanin C; Kozak M; Sumnik Z; Cobelli C; Petruzelkova L
    Diabetes Technol Ther; 2020 Feb; 22(2):112-120. PubMed ID: 31769699
    [No Abstract]   [Full Text] [Related]  

  • 36. Artificial pancreas: model predictive control design from clinical experience.
    Toffanin C; Messori M; Di Palma F; De Nicolao G; Cobelli C; Magni L
    J Diabetes Sci Technol; 2013 Nov; 7(6):1470-83. PubMed ID: 24351173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient Randomized Crossover Automated Insulin Delivery Versus Conventional Therapy with Induced Stress Challenges.
    Kaur RJ; Deshpande S; Pinsker JE; Gilliam WP; McCrady-Spitzer S; Zaniletti I; Desjardins D; Church MM; Doyle Iii FJ; Kremers WK; Dassau E; Kudva YC
    Diabetes Technol Ther; 2022 May; 24(5):338-349. PubMed ID: 35049354
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
    Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
    J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.